TableEdit
OMP ST:1116 ! Escherichia coli K-12 JW0623
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
See Help for Help on this wiki. See the documentation for how to use the table editor
A conflict has been detected between the version of this table in the wiki and the copy you are editing.Rows in conflict with the working copy:
Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes | |
---|---|---|---|---|---|---|---|---|---|---|---|
public |
OMP_AN:28888 |
OMP:0007075 |
decreased growth factor requirement |
Relative to: OMP_AN:27601 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| |
public |
OMP_AN:28889 |
OMP:0007070 |
decreased organic carbon source utilization |
Relative to: OMP_AN:27611 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| |
public |
OMP_AN:28890 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27518 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:2955) Azithromycin |
| |
public |
OMP_AN:28891 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27571 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3259) CCCP (Carbonyl cyanide 3-chlorophenylhydrazone) |
| |
public |
OMP_AN:28892 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:27535 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31380) Cefsulodin sodium salt hydrate |
| |
public |
OMP_AN:28893 |
OMP:0006037 |
increased resistance to macrolide |
Relative to: OMP_AN:27519 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3732) Clarithromycin |
| |
public |
OMP_AN:28894 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27540 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:63598) Levofloxacin |
| |
public |
OMP_AN:28895 |
OMP:0007377 |
decreased resistance to an alkylating agent |
Relative to: OMP_AN:27502 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:25255) methyl methanesulfonate (MMS) |
| |
public |
OMP_AN:28896 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27505 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:165528) Methotrexate hydrate |
| |
public |
OMP_AN:28897 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27510 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:27504) Mitomycin C |
| |
public |
OMP_AN:28898 |
OMP:0007886 |
decreased resistance to a metal |
Relative to: OMP_AN:27580 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53542) Nickel stress-Ni(II)Cl2 hexahydrate |
| |
public |
OMP_AN:28899 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27513 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8055) Phenazine methosulfate (PMS) |
| |
public |
OMP_AN:28900 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27546 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8653) Pyocyanin |
| |
public |
OMP_AN:28901 |
OMP:0007896 |
decreased resistance to a surfactant |
Relative to: OMP_AN:27582 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8984) SDS |
| |
public |
OMP_AN:28902 |
OMP:0007902 |
increased resistance to bile acids |
Relative to: OMP_AN:27584 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:23687511) Taurocholic acid sodium salt hydrate |
| |
public |
OMP_AN:28903 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27554 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:29699) Tunicamycin |
| |
public |
OMP_AN:28904 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27568 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53188) (±)-Verapamil hydrochloride |
| |
public |
OMP_AN:28905 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27541 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:3864541) Nalidixic acid sodium salt |
| |
public |
OMP_AN:28906 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27542 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:100246) Norfloxacin |
| |
public |
OMP_AN:28907 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27504 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31924) Novobiocin sodium salt |
| |
public |
OMP_AN:28908 |
OMP:0007010 |
decreased population growth at alkaline pH |
Relative to: OMP_AN:27623 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (**SID:24900259) TAPS |
| |
public |
OMP_AN:28909 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27551 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28077) Rifampicin |
| |
public |
OMP_AN:28910 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27500 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:45924) Trimethoprim |
|
The rows shown above are different from the working copy.
This includes rows that have been edited and rows that are missing in the copy you are editing.
Copy desired rows to the working version until you have what you need, then continue editing.
Working copy:
The highlighted rows are different from the copy of the table from the wiki. This includes rows that have been edited and rows that you added. You can delete rows from the working copy in this view before continuing.Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes | |
---|---|---|---|---|---|---|---|---|---|---|---|
public |
OMP_AN:1031 |
OMP:0007092 |
decreased cell motility by swarming |
Relative to: OMP_AN:881 Genotype differences: +DE(araD-araB)567 +DE(rhaD-rhaB)568 +hsdR514 +lacZ4787(del)( +lipA767(del) -IN(rrnD-rrnE)1 Condition differences: no differences |
|
ECO:0005803 |
motility assay evidence |
PMID:17122336 |
|||
public |
OMP_AN:28888 |
OMP:0007075 |
decreased growth factor requirement |
Relative to: OMP_AN:27601 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| |
public |
OMP_AN:28889 |
OMP:0007070 |
decreased organic carbon source utilization |
Relative to: OMP_AN:27611 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| |
public |
OMP_AN:28890 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27518 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:2955) Azithromycin |
| |
public |
OMP_AN:28891 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27571 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3259) CCCP (Carbonyl cyanide 3-chlorophenylhydrazone) |
| |
public |
OMP_AN:28892 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:27535 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31380) Cefsulodin sodium salt hydrate |
| |
public |
OMP_AN:28893 |
OMP:0006037 |
increased resistance to macrolide |
Relative to: OMP_AN:27519 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:3732) Clarithromycin |
| |
public |
OMP_AN:28894 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27540 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:63598) Levofloxacin |
| |
public |
OMP_AN:28895 |
OMP:0007377 |
decreased resistance to an alkylating agent |
Relative to: OMP_AN:27502 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:25255) methyl methanesulfonate (MMS) |
| |
public |
OMP_AN:28896 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27505 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:165528) Methotrexate hydrate |
| |
public |
OMP_AN:28897 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27510 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:27504) Mitomycin C |
| |
public |
OMP_AN:28898 |
OMP:0007886 |
decreased resistance to a metal |
Relative to: OMP_AN:27580 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53542) Nickel stress-Ni(II)Cl2 hexahydrate |
| |
public |
OMP_AN:28899 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27513 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8055) Phenazine methosulfate (PMS) |
| |
public |
OMP_AN:28900 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27546 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8653) Pyocyanin |
| |
public |
OMP_AN:28901 |
OMP:0007896 |
decreased resistance to a surfactant |
Relative to: OMP_AN:27582 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:8984) SDS |
| |
public |
OMP_AN:28902 |
OMP:0007902 |
increased resistance to bile acids |
Relative to: OMP_AN:27584 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:23687511) Taurocholic acid sodium salt hydrate |
| |
public |
OMP_AN:28903 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27554 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:29699) Tunicamycin |
| |
public |
OMP_AN:28904 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27568 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:53188) (±)-Verapamil hydrochloride |
| |
public |
OMP_AN:28905 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27541 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CID:3864541) Nalidixic acid sodium salt |
| |
public |
OMP_AN:28906 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27542 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:100246) Norfloxacin |
| |
public |
OMP_AN:28907 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27504 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:31924) Novobiocin sodium salt |
| |
public |
OMP_AN:28908 |
OMP:0007010 |
decreased population growth at alkaline pH |
Relative to: OMP_AN:27623 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (**SID:24900259) TAPS |
| |
public |
OMP_AN:28909 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27551 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:28077) Rifampicin |
| |
public |
OMP_AN:28910 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27500 Genotype differences: +lacZ4787(del)( +lipA767(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
PMID:21185072 |
towards some (CHEBI:45924) Trimethoprim |
|
Cancel |